PANCREAS ADENOCARCINOMA (MSI-H)
Clinical trials for PANCREAS ADENOCARCINOMA (MSI-H) explained in plain language.
Never miss a new study
Get alerted when new PANCREAS ADENOCARCINOMA (MSI-H) trials appear
Sign up with your email to follow new studies for PANCREAS ADENOCARCINOMA (MSI-H), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could new ultrasound tech spot pancreatic cancer more accurately?
Diagnosis Not yet recruitingThis study tests two new ultrasound techniques to help doctors tell the difference between common pancreatic cancer and other types of pancreatic growths. About 150 adults with a solid pancreatic mass will get these advanced scans. The goal is to see if these methods can improve …
Matched conditions: PANCREAS ADENOCARCINOMA (MSI-H)
Phase: NA • Sponsor: GCS Ramsay Santé pour l'Enseignement et la Recherche • Aim: Diagnosis
Last updated Jun 15, 2026 19:03 UTC
-
Gene test could tailor chemo for tough pancreatic cancers
Knowledge-focused Not yet recruitingThis study aims to see if using a genetic test (transcriptomic signature) to choose chemotherapy improves outcomes for people with borderline resectable pancreatic cancer. About 367 participants will receive standard chemotherapy, and researchers will track how long they live wit…
Matched conditions: PANCREAS ADENOCARCINOMA (MSI-H)
Phase: NA • Sponsor: Institut Paoli-Calmettes • Aim: Knowledge-focused
Last updated Jun 17, 2026 05:43 UTC